Selskabets formål er at drive investeringsvirksomhed samt direkte eller indirekte at drive fabrikation af og handel med bioteknologiske og kemiske produkter, processer og anlæg, samt at drive forsknings- og rådgivningsvirksomhed og anden virksomhed, der efter bestyrelsens skøn er forbundet dermed. Selskabet søger i enhver henseende at drive sin virksomhed på social, miljømæssig og økonomisk ansvarlig vis.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 6.8 mia. | 2.1 mia. | 16.8 mia. | 11.3 mia. | 1629 | |
CVR: 12516479
Secondary names: CHR. HANSEN'S LAB. DANMARK A/S, CHR. HANSEN'S A/S, CHL FOOD INGREDIENTS A/S
Previous names: A/S PSE NR. 2770, CHR. HANSEN'S LABORATORIUM DANMARK A/S
4 properties
Upgrade to Pro to see addresses, building data and ownership details
Companies in the same industry and area
Ingermarie Jensen joined the board
Tobias Vode Kornbeck Bramminge joined the board
Charlotte Lund joined the board
Jens Græsted left the board
Dejan Stanisavic left the board
Ingermarie Jensen left the board
Compared to 50 companies in Fremstilling af andre kemiske produkter i.a.n.
Comparison is based on industry median values
The financial health of CHR. HANSEN A/S appears robust, with a significant increase in revenue and profit over the past few years. In 2025, the company reported revenue of 6.82 billion DKK and a profit of 2.11 billion DKK, reflecting a strong upward trend from 5.41 billion DKK in revenue and 812 million DKK in profit in 2021. Equity has also shown consistent growth, reaching 11.26 billion DKK in 2025, indicating a solid financial foundation. However, the notable drop in revenue from 2023 to 2024 (8.3 billion DKK to 6.72 billion DKK) raises concerns about market fluctuations. With over 1,000 employees, CHR. HANSEN A/S holds a significant position in the chemical manufacturing industry, leveraging its strong equity and profitability to navigate potential challenges.
AI-generated summary
companydata.dk